kcgi cmo

Bio & Pharma Samsung Biologics bags $514 mn CMO contract from US pharma

Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO), said on Monday it has secured a $5.14 million order from...

Bio & Pharma Samsung Biologics signs $1.4 bn CMO deal with European pharma

South Korea's Samsung Biologics Co., the world’s largest contract drugmaker, said on Tuesday it signed a $1.4 billion contract manufacturing o...

Mergers & Acquisitions KCGI buys control of Hanyang Securities for $166 mn

KCGI, a South Korean private equity firm, has agreed to buy a controlling stake in Hanyang Securities Co. for 220.3 billion won ($166 million), slig...

Mergers & Acquisitions Activst fund KCGI struggles to fund Hanyang Securities deal

KCGI, a South Korean private equity firm, has been struggling to raise funds for its 244.9-billion-won ($183 million) purchase of a controlling stak...

Banking & Finance Activist fund KCGI to buy Hanyang Securities for $180 mn

South Korean private equity firm KCGI Co. is expected to acquire local brokerage house Hanyang Securities Co. for 244.9 billion won ($179.8 million)...

Mergers & Acquisitions Hanyang Securities stake draws bids without sale manager

Hanyang Securities Co. has received preliminary bids from four to five South Korean companies or consortia for its 11.3% stake after its controlling...

Mergers & Acquisitions Hanyang Securities up for sale; in talks with KCGI, Woori

Hanyang Securities Co., a small South Korean brokerage firm, has been put on the market as its parent Hanyang University Foundation scrambles to kee...

Bio & Pharma Samsung’s biotech duo on a roll with $1.1 bn CMO order

Samsung Group is on track to rise to the top of biosimilar companies in the world and become South Korea’s largest drug maker for contract man...

Bio & Pharma Samsung Biologics reaches record-breaking annual orders

Samsung Biologics Co., the world’s top contract manufacturing organization (CMO) by capacity, surpassed the annual contract manufacturing orde...

Corporate governance Hyundai Group chair exits Schindler-invested unit board

Hyundai Group's chairwoman on Friday resigned from the board of its elevator unit, whose No. 2 shareholder is Schindler Holding AG, amid mounting sh...

Korean stock market KCGI Asset Management appoints former KIS head as new CMO

South Korea’s KCGI Asset Management, formerly Meritz Asset Management, announced on Friday that it has hired Cho Won-bok, former division head...

Bio & Pharma SK Bioscience buys 6.5 million Novavax shares for $83.4 million

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...

Shareholder activism KCGI’s ascent to intensify family feud over DB control; DB stocks rally

A sibling feud over management control of DB Group is expected to intensify following the ascent of South Korean activist fund Korea Corporate Gover...

Shareholder activism S.Korean activist fund KCGI eyes foundry DB HiTek buyout

Korea Corporate Governance Improvement Fund (KCGI) is eyeing a controlling stake in DB HiTek Co. as the activist fund became the second-largest shar...

Korean chipmakers Chip foundry DB HiTek's stock near 10-month peak on activist fund

South Korean leading foundry chipmaker DB HiTek’s stock price hit a near 10-month high this week as a domestic activist fund bought a stake to...

Bio & Pharma Samsung Biologics bags $183 million CMO order from Pfizer

Samsung Biologics Co., the world’s No. 1 contract drug maker in terms of production capacity, has won a $182.7 million contract manufacturing ...

Bio & Pharma Brazil approves Celltrion Pharm’s syringe facility

Celltrion Pharm Inc., a South Korean biopharmaceutical company, said on Monday it received certification from Brazil’s health regulator for it...

Shareholder activism Activist fund KCGI to sell Osstem stake to UCK, MBK Partners

Korea Corporate Governance Improvement Fund (KCGI), one of the country’s most aggressive shareholder activists, plans to sell its stake in Oss...

Mergers & Acquisitions MBK, Unison to expand Osstem Implant's target reach beyond China

South Korean private equity firm Unison Capital Korea is set to focus on boosting the corporate value of Osstem Implant Co., once the PE manager and...

Mergers & Acquisitions Korean activist fund KCGI buys Meritz Asset Management

A consortium led by Korea Corporate Governance Improvement Fund (KCGI), a local activist fund, said on Jan. 9 it signed a share purchase agreement l...

Mergers & Acquisitions Korea's Meritz Group likely to sell off its asset management arm

South Korea’s Meritz Financial Group Inc. is poised to sell off its subsidiary Meritz Asset Management Co., The Korea Economic Daily understoo...

Bio & Pharma Korea's Samsung Biologics signs $296 mn CMO deal with GSK

South Korea’s Samsung Biologics Co. has signed a $296.1 million deal to supply biopharmaceutical products to UK-based multinational pharma gia...

Bio & Pharma Samsung Biologics signs $81 mn CMO deal with Novartis

South Korea’s Samsung Biologics Co. has inked an $81 million contract manufacturing deal with Novartis, the world’s fifth-largest pharma...

Private equity Lessons learned from activist fund’s KAL exit

Activist fund Korea Corporate Governance Improvement Fund (KCGI) recently exited its investment in Hanjin KAL Co., the parent company of Korean Air ...

COVID-19 SK seeks to make Pfizer, Merck COVID-19 pills in CMO deals

SK Inc., the investment and holding company of South Korea’s SK Group, is seeking to make COVID-19 treatment pills developed by Pfizer Inc. an...

Pharamaceuticals Korea’s Genome & Company aims US CMO market

South Korea’s microbiome medicine developer Genome & Company geared up for entering the U.S. market to boost profits and make inroads into...

Mergers & Acquisitions Korean activist fund KCGI joins in consortium to buy Ssangyong

A South Korean electric bus maker Edison Motors Co. added the activist fund Korea Corporate Government Improvement Fund (KCGI) as a financial invest...

COVID-19 CureVac may pick Korea as Asian base for COVID vaccine production

German biopharmaceutical company CureVac N.V. may choose South Korea as one of its global production bases for the COVID-19 vaccine following Korean...

Korean food SK acquires 70% stake in Yposkesi to jump into cell, gene CMO business

SK Inc., the holding and investment company of SK Group, South Korea’s third-largest conglomerate, has acquired a 70% stake in Yposkesi, a Fre...

Biopharma CMO Moderna deal shows Korea’s prowess as global hub for biopharma CMO

South Korea is emerging as a global hub for the contract manufacturing of biopharmaceuticals following its latest deal to procure COVID-19 vaccines ...